Skip to main content
Figure 4 | Journal of Negative Results in BioMedicine

Figure 4

From: Biological constraints limit the use of rapamycin-inducible FKBP12-Inp54p for depleting PIP2 in dorsal root ganglia neurons

Figure 4

Rapamycin treatment of Rosa-FRBPLF/CGRP-Inp54p mice did not affect hypersensitivity following inflammation. A-C) Control experiments with CGRP-Inp54p+/− mice. A) Edema, B) noxious thermal hyperalgesia and C) mechanical allodynia following intraplantar injection of CFA. No significant differences between genotypes before or after CFA injection. n = 12 male mice per genotype. D-F) Rosa-FRBPLF/CGRP-Inp54p double heterozygous mice. D) Edema, E) noxious thermal hyperalgesia and F) mechanical allodynia following intraplantar injection of CFA. Black arrows indicate i.t. rapamycin (1 nmol) injections, red arrows indicate intraplantar CFA injection. No significant differences between genotypes before or after CFA injection. n = 10 male mice per genotype.

Back to article page